| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
2e-08 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-06 |
| mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.43 |
5e-05 |
| mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
| mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |